rheumatology
Musculoskeletal

News in brief: Most important MSK trials impacted by pandemic: experts; Impact of arthritis ‘pervasive’ for patients; Upadacitinib gets PBAC tick for AS and severe PsA

Most important MSK trials impacted by pandemic: experts Important musculoskeletal clinical trials designed to answer the most pressing clinical questions in the field have been or will be affected by the COVID-19 pandemic, researchers warn. In a survey completed by 109 ANZMUSC members almost half said their professional life and/or musculoskeletal research work had been ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic